[Blockade of the PDGF receptor: a new and effective therapy option for NPM-ALK-dependent lymphoma]

Pathologe. 2014 Nov:35 Suppl 2:185-6. doi: 10.1007/s00292-014-2008-x.

[Article in German]

Author

D Laimer-Gruber¹

Affiliation

¹ Medizinische Universität Wien, Spitalgasse 23, 1090, Wien, Österreich, [email protected].

PMID: 25352000
DOI: 10.1007/s00292-014-2008-x

No abstract available

Publication types

Review

MeSH terms

Adolescent
Adult
Animals
Benzamides / adverse effects
Benzamides / therapeutic use*
Child
Humans
Imatinib Mesylate
Lymph Nodes / pathology
Lymphoma, Large-Cell, Anaplastic / drug therapy*
Lymphoma, Large-Cell, Anaplastic / genetics*
Lymphoma, Large-Cell, Anaplastic / metabolism
Lymphoma, Large-Cell, Anaplastic / pathology
Mice
Multimodal Imaging
Piperazines / adverse effects
Piperazines / therapeutic use*
Positron-Emission Tomography
Protein-Tyrosine Kinases / genetics*
Pyrimidines / adverse effects
Pyrimidines / therapeutic use*
Receptors, Platelet-Derived Growth Factor / antagonists & inhibitors*
Tomography, X-Ray Computed
Young Adult

Substances

Benzamides
Piperazines
Pyrimidines
Imatinib Mesylate
p80(NPM-ALK) protein
Protein-Tyrosine Kinases
Receptors, Platelet-Derived Growth Factor